Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
or

Qiagen N.V. (QGEN)

Qiagen N.V. (QGEN)
38.62 x 100 39.99 x 100
Post-market by (Cboe BZX)
39.48 +0.58 (+1.49%) 03/14/25 [NYSE]
38.62 x 100 39.99 x 100
Post-market 39.48 unch (unch) 16:33 ET
Quote Overview for Fri, Mar 14th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
38.92
Day High
39.51
Open 39.21
Previous Close 38.90 38.90
Volume 858,400 858,400
Avg Vol 1,186,785 1,186,785
Stochastic %K 65.20% 65.20%
Weighted Alpha -16.15 -16.15
5-Day Change -0.27 (-0.68%) -0.27 (-0.68%)
52-Week Range 37.63 - 49.30 37.63 - 49.30
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,630,315
  • Shares Outstanding, K 221,859
  • Annual Sales, $ 1,978 M
  • Annual Income, $ 83,590 K
  • EBIT $ 98 M
  • EBITDA $ 319 M
  • 60-Month Beta 0.44
  • Price/Sales 4.42
  • Price/Cash Flow 12.27
  • Price/Book 2.45

Options Overview Details

View History
  • Implied Volatility 39.89% ( +2.89%)
  • Historical Volatility 26.28%
  • IV Percentile 83%
  • IV Rank 68.24%
  • IV High 47.66% on 04/15/24
  • IV Low 23.22% on 11/22/24
  • Put/Call Vol Ratio 5.00
  • Today's Volume 6
  • Volume Avg (30-Day) 285
  • Put/Call OI Ratio 0.12
  • Today's Open Interest 6,275
  • Open Int (30-Day) 6,978

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.49
  • Number of Estimates 8
  • High Estimate 0.50
  • Low Estimate 0.48
  • Prior Year 0.47
  • Growth Rate Est. (year over year) +4.26%

Price Performance

See More
Period Period Low Period High Performance
1-Month
37.63 +4.92%
on 03/04/25
Period Open: 39.87
40.21 -1.82%
on 02/18/25
-0.39 (-0.98%)
since 02/14/25
3-Month
37.63 +4.92%
on 03/04/25
Period Open: 46.70
49.30 -19.92%
on 01/22/25
-7.22 (-15.46%)
since 12/13/24
52-Week
37.63 +4.92%
on 03/04/25
Period Open: 45.28
49.30 -19.92%
on 01/22/25
-5.80 (-12.80%)
since 03/14/24

Most Recent Stories

More News
2 Recent Stock Splits You've Never Heard of That Certain Wall Street Analysts Think Could Soar 39% and 62%

Stock splits can be undertaken for several reasons. They can bring a stock's price down to make it more affordable for a wider range of investors. They can increase a stock price if it's too low, which...

MTH : 70.42 (+1.46%)
QGEN : 39.48 (+1.49%)
Hologic Hits New 52-Week Low: How to Play the Stock Now?

Shares of Hologic HOLX recorded a new 52-week low of $69.46 during Monday’s trading before finishing slightly higher at $70.29. Yesterday, the stock ended at $70.20, marking the lowest close in recent...

HOLX : 60.71 (+0.02%)
BDX : 225.98 (+1.43%)
QGEN : 39.48 (+1.49%)
QIAGEN Launches New Custom Solutions for Enhanced Microbial Analysis

QIAGEN launched custom tools for designing microbial assays, enhancing digital PCR and NGS capabilities for researchers.Quiver AI SummaryQIAGEN has launched two innovative tools designed to enhance microbial...

QGEN : 39.48 (+1.49%)
Hologic Post Q4 Earnings Miss: Time to Buy, Hold or Sell the Stock?

On Monday, Hologic HOLX released its fiscal 2024 fourth-quarter financial report after the closing bell, with revenues slightly surpassing the consensus mark. The bottom line fell short of estimates...

HOLX : 60.71 (+0.02%)
BDX : 225.98 (+1.43%)
QGEN : 39.48 (+1.49%)
QIAGEN Stock Flat Post Q3 Earnings & Revenue Beat, 2024 EPS View Up

QIAGEN N.V.’s QGEN third-quarter 2024 adjusted earnings per share (EPS) were 57 cents, 58 cents at the constant exchange rate (CER). The reported figure increased 14% from the 2023 comparable figure...

DGX : 170.16 (+0.79%)
BSX : 97.16 (+1.88%)
QGEN : 39.48 (+1.49%)
ISRG : 484.44 (+1.61%)
Reasons to Retain QIAGEN Stock in Your Portfolio for Now

QIAGEN N.V. QGEN is well-poised to grow in the coming quarter, driven by its strategic alliances with researchers and pharma companies. The company’s expansive next-generation sequencing (NSG) portfolio...

AXGN : 17.25 (+0.52%)
PAHC : 21.25 (+3.71%)
QGEN : 39.48 (+1.49%)
TMDX : 68.53 (+6.50%)
Bio-Rad Laboratories Stock: Is BIO Underperforming the Healthcare Sector?

Despite Bio-Rad Laboratories’ underperformance relative to the healthcare sector over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

XLV : 144.93 (+0.76%)
BIO : 254.45 (+3.85%)
QGEN : 39.48 (+1.49%)
With HOLX Stock Near 52-Week High, Should You Buy More or Play Safe?

Shares of Hologic HOLX are showing impressive gains of late, trading quite near its 52-week high of $84.67. The stock closed Thursday at $80.99, just 4.3% below the highest point. In the past three months,...

BDX : 225.98 (+1.43%)
HOLX : 60.71 (+0.02%)
QGEN : 39.48 (+1.49%)
Qiagen: Q1 Earnings Snapshot

Qiagen: Q1 Earnings Snapshot

QGEN : 39.48 (+1.49%)
3 Unusually Active Call Options to Buy With Just 5% Down

Investors continue to wonder how long stocks will keep moving higher. Friday’s jobs report suggests the economy is much stronger than most people realize, which is good news for stocks.

QGEN : 39.48 (+1.49%)
MSFT : 388.56 (+2.58%)
AAPL : 213.49 (+1.82%)
BRK.B : 514.60 (+2.05%)
NVDA : 121.67 (+5.27%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

QIAGEN N.V. is one of the world's leading providers of technologies and products for the separation, purification and handling of nucleic acids DNA/RNA. The company provides innovative technologies and products for pre-analytical sample preparation and molecular diagnostics solutions. It has developed...

See More

Key Turning Points

3rd Resistance Point 40.28
2nd Resistance Point 39.89
1st Resistance Point 39.69
Last Price 39.48
1st Support Level 39.10
2nd Support Level 38.71
3rd Support Level 38.51

See More

52-Week High 49.30
Fibonacci 61.8% 44.84
Fibonacci 50% 43.46
Fibonacci 38.2% 42.09
Last Price 39.48
52-Week Low 37.63

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals